OpenLight Introduces 224G InP-based Modulator to Advance PIC Designs for Datacom Market

New Modulator Increases Speed and Scale to 224G/λ for Future High-Speed Applications OpenLight today announced that it developed and successfully demonstrated a 224G InP-based modulator available for Tower’s PH18DA platform. Measured as part of a fully operational photonic integrated circuit (PIC), OpenLight extended the speed of its PAM4 modulator and demonstrated a PAM4 224G eye. This new 224G […]

thaipr.net

7 มี.ค. 66

OpenLight Announces Availability of First Process Design Kit Sampler to Accelerate Component Testing

New Product Offers Lab-Testing Flexibility and Enhances PIC Design Accuracy to Accelerate Time to Market To enhance familiarity with process technologies and increase the accessibility of photonic integrated circuits (PICs), OpenLight today announced the general availability of its process design kit (PDK) Sampler. The PDK Sampler is a unique, die-level PIC which contains OpenLight’s standard PDK components, […]

thaipr.net

2 มี.ค. 66

OpenLight Unveils First 800G DR8 Photonic Integrated Circuit Design to Advance Global Datacenter Interconnect Industry

Fully validated design provides customers with a shortcut to create 800G DR8 transceivers and accelerate customer time to market for data center applications Delivering new levels of performance and scalability to accelerate the design of photonic integrated circuits (PICs) for datacom applications, OpenLight today announced the availability of its first 800G DR8 PIC design targeted at datacenter […]

thaipr.net

15 ธ.ค. 65

OpenLight Announces Process Design Kit Availability with Industry’s First Unified Electronic and Photonic Design Platform

New Offering Enables Fast, Accurate and Reliable Photonic IC Designs with On-Chip Laser Technology To streamline the end-to-end design of photonic integrated circuits (PICs) and meet future demands of applications including datacom, telecom, LiDAR, healthcare, HPC, AI, and optical computing, OpenLight today announced the general availability of its process design kit (PDK). The OpenLight PDK is ready […]

thaipr.net

23 พ.ย. 65

Introducing Arta Finance: the digital family office for the world – using technology to unlock the financial superpowers of the ultra-wealthy

Arta Finance has raised more than $90M from Sequoia Capital India, Ribbit Capital, Coatue Management and more than 140 angel investors to unlock the financial superpowers of the ultra-wealthy by making family office services available to everyone. Arta Finance, a Digital Family Office, unveiled its platform today, starting with accredited investors in the United States. […]

thaipr.net

3 พ.ย. 65

Turn Biotechnologies launches eTurna™ delivery platform designed specifically to enable nucleic acid therapeutics

The proprietary platform is versatile, equally effective with different cargoes, routes of administration Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced it has created a novel platform to safely and effectively deliver nucleic acid therapeutics – a major expansion of the company’s business. The eTurna Platform™ […]

thaipr.net

14 ก.ย. 65

Prominent ophthalmologist will guide Turn Bio’s search for therapies to cure eye diseases

Albert Wu, MD, PhD, a recognized advocate of using stem cell therapy to treat eye conditions, will advise company’s development of ocular tissue rejuvenation therapeutics Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that Albert Wu, MD, PhD, will oversee its development of ophthalmic therapeutic products as […]

thaipr.net

23 ส.ค. 65

Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio

Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique […]

thaipr.net

9 ส.ค. 65
1 2